Mangalam Drugs and Organics Limited
Board Meeting Details
A meeting of the Board of Directors is scheduled to be held on Wednesday, August 12th, 2026 at the registered office of the Company situated at 3rd Floor, Rupam Building, 239, P. D'Mello Road, Near G.P.O., Mumbai, Maharashtra-400001.
Agenda Items
The Board will consider the following businesses:
1. Financial Results: To consider, approve and take on record the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended June 30, 2026.
2. Secretarial Auditor Appointment: To consider and appoint M/s L.N. Joshi & Co. Practicing Company Secretaries (CP No.: 4216), as Secretarial Auditors of the Company for a period of five consecutive years from conclusion of 53rd AGM to 58th AGM of the Company, subject to approval of the members at the ensuing 53rd AGM.
3. Statutory Auditor Appointment: To consider and appoint M/s S.N. Nanda & Co. Chartered Accountants (FRN:000685N) as Statutory Auditor in place of the Retiring Statutory Auditor M/s V.S. Somani & Co., Chartered Accountants (FRN: 117589W) upon completion of their term.
Trading Window Closure
In terms of SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's internal code of conduct:
- The Trading Window for dealing in the securities of the Company has been closed for Directors/Officers and designated employees of the Company from July 1, 2026
- The Trading Window shall remain closed until the expiry of 48 hours from the announcement/declaration of the Un-audited Financial Results of the Company for the quarter ended June 30, 2026
- The closure of Trading Window has been informed to all Designated Persons covered by the Code